Cargando…

Transporter proteins knowledge graph construction and its application in drug development

Transporters are the main determinant for pharmacokinetics characteristics of drugs, such as absorption, distribution, and excretion of drugs in humans. However, it is difficult to perform drug transporter validation and structure analysis of membrane transporter proteins by experimental methods. Ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiao-Hui, Ruan, Yao, Liu, Yan-Guang, Duan, Xin-Ya, Jiang, Feng, Tang, Hao, Zhang, Hong-Yu, Zhang, Qing-Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206172/
https://www.ncbi.nlm.nih.gov/pubmed/37235186
http://dx.doi.org/10.1016/j.csbj.2023.05.001
_version_ 1785046169152389120
author Chen, Xiao-Hui
Ruan, Yao
Liu, Yan-Guang
Duan, Xin-Ya
Jiang, Feng
Tang, Hao
Zhang, Hong-Yu
Zhang, Qing-Ye
author_facet Chen, Xiao-Hui
Ruan, Yao
Liu, Yan-Guang
Duan, Xin-Ya
Jiang, Feng
Tang, Hao
Zhang, Hong-Yu
Zhang, Qing-Ye
author_sort Chen, Xiao-Hui
collection PubMed
description Transporters are the main determinant for pharmacokinetics characteristics of drugs, such as absorption, distribution, and excretion of drugs in humans. However, it is difficult to perform drug transporter validation and structure analysis of membrane transporter proteins by experimental methods. Many studies have demonstrated that knowledge graphs (KG) could effectively excavate potential association information between different entities. To improve the effectiveness of drug discovery, a transporter-related KG was constructed in this study. Meanwhile, a predictive frame (AutoInt_KG) and a generative frame (MolGPT_KG) were established based on the heterogeneity information obtained from the transporter-related KG by the RESCAL model. Natural product Luteolin with known transporters was selected to verify the reliability of the AutoInt_KG frame, its ROC-AUC (1:1), ROC-AUC (1:10), PR-AUC (1:1), PR-AUC (1:10) are 0.91, 0.94, 0.91 and 0.78, respectively. Subsequently, the MolGPT_KG frame was constructed to implement efficient drug design based on transporter structure. The evaluation results showed that the MolGPT_KG could generate novel and valid molecules and that these molecules were further confirmed by molecular docking analysis. The docking results showed that they could bind to important amino acids at the active site of the target transporter. Our findings will provide rich information resources and guidance for the further development of the transporter-related drugs.
format Online
Article
Text
id pubmed-10206172
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Research Network of Computational and Structural Biotechnology
record_format MEDLINE/PubMed
spelling pubmed-102061722023-05-25 Transporter proteins knowledge graph construction and its application in drug development Chen, Xiao-Hui Ruan, Yao Liu, Yan-Guang Duan, Xin-Ya Jiang, Feng Tang, Hao Zhang, Hong-Yu Zhang, Qing-Ye Comput Struct Biotechnol J Research Article Transporters are the main determinant for pharmacokinetics characteristics of drugs, such as absorption, distribution, and excretion of drugs in humans. However, it is difficult to perform drug transporter validation and structure analysis of membrane transporter proteins by experimental methods. Many studies have demonstrated that knowledge graphs (KG) could effectively excavate potential association information between different entities. To improve the effectiveness of drug discovery, a transporter-related KG was constructed in this study. Meanwhile, a predictive frame (AutoInt_KG) and a generative frame (MolGPT_KG) were established based on the heterogeneity information obtained from the transporter-related KG by the RESCAL model. Natural product Luteolin with known transporters was selected to verify the reliability of the AutoInt_KG frame, its ROC-AUC (1:1), ROC-AUC (1:10), PR-AUC (1:1), PR-AUC (1:10) are 0.91, 0.94, 0.91 and 0.78, respectively. Subsequently, the MolGPT_KG frame was constructed to implement efficient drug design based on transporter structure. The evaluation results showed that the MolGPT_KG could generate novel and valid molecules and that these molecules were further confirmed by molecular docking analysis. The docking results showed that they could bind to important amino acids at the active site of the target transporter. Our findings will provide rich information resources and guidance for the further development of the transporter-related drugs. Research Network of Computational and Structural Biotechnology 2023-05-03 /pmc/articles/PMC10206172/ /pubmed/37235186 http://dx.doi.org/10.1016/j.csbj.2023.05.001 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Chen, Xiao-Hui
Ruan, Yao
Liu, Yan-Guang
Duan, Xin-Ya
Jiang, Feng
Tang, Hao
Zhang, Hong-Yu
Zhang, Qing-Ye
Transporter proteins knowledge graph construction and its application in drug development
title Transporter proteins knowledge graph construction and its application in drug development
title_full Transporter proteins knowledge graph construction and its application in drug development
title_fullStr Transporter proteins knowledge graph construction and its application in drug development
title_full_unstemmed Transporter proteins knowledge graph construction and its application in drug development
title_short Transporter proteins knowledge graph construction and its application in drug development
title_sort transporter proteins knowledge graph construction and its application in drug development
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206172/
https://www.ncbi.nlm.nih.gov/pubmed/37235186
http://dx.doi.org/10.1016/j.csbj.2023.05.001
work_keys_str_mv AT chenxiaohui transporterproteinsknowledgegraphconstructionanditsapplicationindrugdevelopment
AT ruanyao transporterproteinsknowledgegraphconstructionanditsapplicationindrugdevelopment
AT liuyanguang transporterproteinsknowledgegraphconstructionanditsapplicationindrugdevelopment
AT duanxinya transporterproteinsknowledgegraphconstructionanditsapplicationindrugdevelopment
AT jiangfeng transporterproteinsknowledgegraphconstructionanditsapplicationindrugdevelopment
AT tanghao transporterproteinsknowledgegraphconstructionanditsapplicationindrugdevelopment
AT zhanghongyu transporterproteinsknowledgegraphconstructionanditsapplicationindrugdevelopment
AT zhangqingye transporterproteinsknowledgegraphconstructionanditsapplicationindrugdevelopment